TMEM114
Transmembrane protein 114
Also known as: TM114_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- B3SHH9
- Gene
- TMEM114
- Ensembl
- ENSG00000232258
- Chromosome
- 16
- Canonical length
- 223 aa
- Protein class
- Disease related genes, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a glycosylated transmembrane protein that plays a role in lens and eye development. Mutations in this gene, including a t(16;22)(p13.3;q11.2) translocation, are associated with congenital and juvenile cataract disorders. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Feb 2014]
Canonical amino-acid sequenceUniProt
223 residues, UniProt reviewed canonical sequence.
>B3SHH9|TMEM114
1 MRVHLGGLAG AAALTGALSF VLLAAAIGTD FWYIIDTERL ERTGPGAQDL LGSINRSQPE
61 PLSSHSGLWR TCRVQSPCTP LMNPFRLENV TVSESSRQLL TMHGTFVILL PLSLILMVFG
121 GMTGFLSFLL QAYLLLLLTG ILFLFGAMVT LAGISVYIAY SAAAFREALC LLEEKALLDQ
181 VDISFGWSLA LGWISFIAEL LTGAAFLAAA RELSLRRRQD QAILocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM114 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- seminal vesicle: 15 nTPM
- hypothalamus: 2.9 nTPM
- pituitary gland: 0.5 nTPM
- epididymis: 0.3 nTPM
- tongue: 0.2 nTPM
- adrenal gland: 0.1 nTPM
Single-cell type
- other brain neurons: 4.6 nCPM
- paneth cells: 3.9 nCPM
- retinal ganglion cells: 3.9 nCPM
- gonadotrophs: 2.4 nCPM
- epicardial cells: 2.3 nCPM
- kupffer cells: 2 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 5 nTPM
- pons: 4.4 nTPM
- midbrain: 2.8 nTPM
- medulla oblongata: 2 nTPM
- cerebral cortex: 1.7 nTPM
- basal ganglia: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.82
- gnomAD pLI
- 0.03
- gnomAD missense Z
- -0.36
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM114 as an antibody target. Whether an autoantibody or antibody against TMEM114 could matter depends on whether native TMEM114 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM114 is annotated at the cell surface, where native TMEM114 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TMEM114 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...